Design, Synthesis, and Evaluation of Indolizine Derivatives as Nonclassical Ferroptosis Inhibitors with Efficacy in Acute Liver Injury and Ischemic Stroke Models
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c03439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Yijing Shu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Green Pharmaceutical Technology Key Laboratory of Luzhou City, School of Pharmacy, Southwest Medical University, Luzhou 646000, P.R. China. Hauptthemen laut MEDLINE: Ferroptosis, Drug Design, Indolizines, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Southwest Medical University, Science and Technology Department of Sichuan Province, Luzhou Science and Technology Bureau.
Themen: Schlaganfall
Abstract (Originalsprache)
Ferroptosis is a regulated form of cell death driven by iron-dependent lipid peroxidation. Inhibiting ferroptosis has emerged as a promising therapeutic strategy, but existing inhibitors suffer from limited chemical diversity and suboptimal drug-likeness. Here, we report 1,3-disubstituted indolizine derivatives as novel noncanonical ferroptosis inhibitors. Through phenotypic screening and SAR optimization, we identified D12 (3-(2-methylbenzoyl)indolizine-1-yl acetate). D12 exhibits nanomolar potency (EC50 = 39.7 nM) in RSL3/erastin-induced PC12 cells, outperforming Fer-1. Mechanistically, D12 acts independently of iron chelation, radical trapping, or direct Nrf2 activation; instead, it alleviates oxidative stress and lipid peroxidation upstream. Compared to Fer-1, D12 displays improved metabolic stability, markedly higher systemic exposure, and robust brain penetration (brain/plasma ratio = 6.31). In vivo, D12 attenuates acetaminophen-induced liver injury and cerebral ischemia-reperfusion injury. These findings establish D12 as a mechanistically distinct, drug-like preclinical candidate and. highlight the indolizine scaffold as a promising new chemotype for ferroptosis-targeted drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Green Pharmaceutical Technology Key Laboratory of Luzhou City, School of Pharmacy, Southwest Medical University, Luzhou 646000, P.R. China.
- School of Pharmacy, Department of Pharmacy of Traditional Chinese Medicine, Southwest Medical University, Luzhou 646000, P.R. China.
- Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Key Laboratory of Medical Electrophysi…
- Central Nervous System Product Research and Development Key Laboratory of Sichuan Province, Southwest Medical University, Luzhou 646000, P.R. China.
ORCID-Profile: Ying Xiong, Yimou Gong, Bowen Lei, Dong Yi, Xia Zhou
Förderung
- Southwest Medical University
- Science and Technology Department of Sichuan Province
- Luzhou Science and Technology Bureau
- National Natural Science Foundation of China
- Central Nervous System Product Research and Development Key Laboratory of Sichuan Province, Sichuan Credit Pharmaceutical CO., Ltd.
Zitieren
APA
Shu, Y., Jiang, Y., Xiong, Y., Huang, S., Lunjie, C., Ye, W., Jian, Y., Gong, Y., Lei, B., Yi, D., Zhang, D., Wu, A. G., Wei, S., Fu, Q., & Zhou, X. (2026). Design, Synthesis, and Evaluation of Indolizine Derivatives as Nonclassical Ferroptosis Inhibitors with Efficacy in Acute Liver Injury and Ischemic Stroke Models. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03439
Vancouver
Shu Y, Jiang Y, Xiong Y, Huang S, Lunjie C, Ye W, et al. Design, Synthesis, and Evaluation of Indolizine Derivatives as Nonclassical Ferroptosis Inhibitors with Efficacy in Acute Liver Injury and Ischemic Stroke Models. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03439
BibTeX
@article{Shu2026,
author = {Shu, Yijing and Jiang, Yuheng and Xiong, Ying and Huang, Sheng and Lunjie, Chen and Ye, Wen and Jian, Yao and Gong, Yimou and Lei, Bowen and Yi, Dong and Zhang, Dan and Wu, An Guo and Wei, Siping and Fu, Qiang and Zhou, Xia},
title = {Design, Synthesis, and Evaluation of Indolizine Derivatives as Nonclassical Ferroptosis Inhibitors with Efficacy in Acute Liver Injury and Ischemic Stroke Models},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c03439}
}
EUVIMED